Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Hansel, TT; Barnes, PJ
   Clinical studies on new drugs
   NEW DRUGS FOR ASTHMA, ALLERGY AND COPD
   
   T.T. Hansel e P.J. Barnes, "Clinical studies on new drugs", PROG R RES, 31, 2001, pp. 48-51
2. Jacoby, DB; Fryer, AD
   Anticholinergic therapy for airway diseases
   LIFE SCIENCES
   
   D.B. Jacoby e A.D. Fryer, "Anticholinergic therapy for airway diseases", LIFE SCI, 68(22-23), 2001, pp. 2565-2572
3. Chavannes, NH; van Schayck, CP
   Quality of life in patients with chronic obstructive pulmonary disease - Which drugs help most?
   BIODRUGS
   
   N.H. Chavannes e C.P. van Schayck, "Quality of life in patients with chronic obstructive pulmonary disease - Which drugs help most?", BIODRUGS, 13(2), 2000, pp. 127-133
4. van Schayck, CP
   Do long-acting beta(2)-adrenergic agonists deserve a different place in guidelines for the treatment of asthma and COPD?
   EUROPEAN RESPIRATORY JOURNAL
   
   C.P. van Schayck, "Do long-acting beta(2)-adrenergic agonists deserve a different place in guidelines for the treatment of asthma and COPD?", EUR RESP J, 15(4), 2000, pp. 631-634
5. Beeh, KM; Welte, T; Buhl, R
   Anticholinergics for treatment of chronic obstructive pulmonary disease (COPD)
   MEDIZINISCHE KLINIK
   
   K.M. Beeh et al., "Anticholinergics for treatment of chronic obstructive pulmonary disease (COPD)", MED KLIN, 95(10), 2000, pp. 552-558
6. Barnes, PJ
   The pharmacological properties of tiotropium
   CHEST
   
   P.J. Barnes, "The pharmacological properties of tiotropium", CHEST, 117(2), 2000, pp. 63-66
7. Barnes, PJ
   Novel approaches and targets for treatment of chronic obstructive pulmonary disease
   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
   
   P.J. Barnes, "Novel approaches and targets for treatment of chronic obstructive pulmonary disease", AM J R CRIT, 160(5), 1999, pp. S72-S79
8. Haddad, EB; Patel, H; Keeling, JE; Yacoub, MH; Barnes, PJ; Belvisi, MG
   Pharmacological characterization of the muscarinic receptor antagonist, glycopyrrolate, in human and guinea-pig airways
   BRITISH JOURNAL OF PHARMACOLOGY
   
   E.B. Haddad et al., "Pharmacological characterization of the muscarinic receptor antagonist, glycopyrrolate, in human and guinea-pig airways", BR J PHARM, 127(2), 1999, pp. 413-420
9. BARNES PJ
   NEW THERAPIES FOR CHRONIC OBSTRUCTIVE PULMONARY-DISEASE
   Thorax
   
   P.J. Barnes, "NEW THERAPIES FOR CHRONIC OBSTRUCTIVE PULMONARY-DISEASE", Thorax, 53(2), 1998, pp. 137-147
10. BARNES PJ
    CHRONIC OBSTRUCTIVE PULMONARY-DISEASE - NEW OPPORTUNITIES FOR DRUG DEVELOPMENT
    Trends in pharmacological sciences
    
    P.J. Barnes, "CHRONIC OBSTRUCTIVE PULMONARY-DISEASE - NEW OPPORTUNITIES FOR DRUG DEVELOPMENT", Trends in pharmacological sciences, 19(10), 1998, pp. 415-423
11. MAESEN FPV; SMEETS JJ; SLEDSENS TJH; WALD FDM; CORNELISSEN PJG
    TIOTROPIUM BROMIDE, A NEW LONG-ACTING ANTIMUSCARINIC BRONCHODILATOR -A PHARMACODYNAMIC STUDY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE (COPD)
    The European respiratory journal
    
    F.P.V. Maesen et al., "TIOTROPIUM BROMIDE, A NEW LONG-ACTING ANTIMUSCARINIC BRONCHODILATOR -A PHARMACODYNAMIC STUDY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE (COPD)", The European respiratory journal, 8(9), 1995, pp. 1506-1513